• 1045 Citations
  • 18 h-Index
1986 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1986 2019

  • 1045 Citations
  • 18 h-Index
  • 66 Article
  • 1 Letter
2019

Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer

Rosati, G., Addeo, R., Aprile, G., Avallone, A., Bilancia, D., Brugnatelli, S., Buccafusca, G., Carlomagno, C., Cordio, S., Delfanti, S., Dell’Aquila, E., Di Bisceglie, M., Di Donato, S., Di Stasi, A., Germano, D., Giuliani, F., Granetto, C., Latiano, T. P., Leo, S., Tralongo, P. & 3 others, Stroppolo, M. E., Venturini, F. & Bianco, S., Nov 1 2019, In : Cancer Chemotherapy and Pharmacology. 84, 5, p. 1089-1096 8 p.

Research output: Contribution to journalArticle

Geriatrics
Colorectal Neoplasms
Polymorphism
Tetracyclines
Oncology

Oxaliplatin-Fluoropyrimidine Combination (XELOX) Therapy Does Not Affect Plasma Amino Acid Levels and Plasma Markers of Oxidative Stress in Colorectal Cancer Surgery Patients: A Pilot Study

Aquilani, R., Brugnatelli, S., Dossena, M., Maestri, R., Delfanti, S., Buonocore, D., Boschi, F., Simeti, E., Condino, A. M. & Verri, M., Nov 5 2019, In : Nutrients. 11, 11

Research output: Contribution to journalArticle

Open Access
oxaliplatin
Colorectal Surgery
colorectal neoplasms
Colorectal Neoplasms
Oxidative Stress
Open Access
Heavy Ion Radiotherapy
Adenocarcinoma
Drug Therapy
Disease-Free Survival
Clinical Protocols
2018
7 Citations (Scopus)
Antibody-Dependent Cell Cytotoxicity
Epidermal Growth Factor Receptor
Natural Killer Cells
Colorectal Neoplasms
Mutation
2017
1 Citation (Scopus)
2016
3 Citations (Scopus)

Surgical spacer placement prior carbon ion radiotherapy (CIRT): An effective feasible strategy to improve the treatment for sacral chordoma

Cobianchi, L., Peloso, A., Vischioni, B., Panizza, D., Fiore, M. R., Fossati, P., Vitolo, V., Iannalfi, A., Ciocca, M., Brugnatelli, S., Dominioni, T., Bugada, D., Maestri, M., Alessiani, M., Valvo, F., Orecchia, R. & Dionigi, P., Aug 9 2016, In : World Journal of Surgical Oncology. 14, 1, 211.

Research output: Contribution to journalArticle

Heavy Ion Radiotherapy
Chordoma
Silicon
Therapeutics
Hand

Surgical spacer placement prior carbon ion radiotherapy (CIRT): An effective feasible strategy to improve the treatment for sacral chordoma

Cobianchi, L., Peloso, A., Vischioni, B., Panizza, D., Fiore, M. R., Fossati, P., Vitolo, V., Iannalfi, A., Ciocca, M., Brugnatelli, S. G., Dominioni, T., Bugada, D., Maestri, M., Alessiani, M., Valvo, F., Orecchia, R. & Dionigi, P., Aug 9 2016, In : World Journal of Surgical Oncology. 14, 1, 211.

Research output: Contribution to journalArticle

Heavy Ion Radiotherapy
Chordoma
Silicon
Therapeutics
Hand
2015
1 Citation (Scopus)

The prognosis of patients with liver metastases from colorectal cancer still depends on anatomical presentation more than on treatments

Gobbi, P. G., Rossi, S., Comelli, M., Ravetta, V., Rosa, L. L., Brugnatelli, S., Corbella, F., Delfanti, S., Abumalouh, I. & Dionigi, P., Aug 1 2015, In : Current Cancer Drug Targets. 15, 6, p. 511-518 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Neoplasm Metastasis
Survival
Liver
Therapeutics
2014
12 Citations (Scopus)
Oncogenic Viruses
Human Herpesvirus 4
Colonic Neoplasms
DNA
Real-Time Polymerase Chain Reaction
2013
5 Citations (Scopus)

Autologous CD133+ cells augment the effect of portal embolization

Canepa, M. C., Quaretti, P., Perotti, C., Vercelli, A., Rademacher, J., Peloso, A., Barbieri, L., Franchi, E., Briani, L., Gaspari, A., Brugnatelli, S., Pedrazzoli, P., Dionigi, P. & Maestri, M., Apr 2013, In : Minerva Chirurgica. 68, 2, p. 163-168 6 p.

Research output: Contribution to journalArticle

Liver
Portal Vein
Cell- and Tissue-Based Therapy
Neoplasms
Medicine
39 Citations (Scopus)

Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer

Peloso, A., Franchi, E., Canepa, M. C., Barbieri, L., Briani, L., Ferrario, J., Bianco, C., Quaretti, P., Brugnatelli, S., Dionigi, P. & Maestri, M., Dec 2013, In : HPB. 15, 12, p. 928-934 7 p.

Research output: Contribution to journalArticle

Indocyanine Green
Optical Imaging
Colorectal Neoplasms
Neoplasm Metastasis
Liver
2012
19 Citations (Scopus)

Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer

Manzoni, M., Mariucci, S., Delfanti, S., Rovati, B., Ronzoni, M., Loupakis, F., Brugnatelli, S., Tinelli, C., Villa, E., Falcone, A. & Danova, M., Jul 2012, In : Journal of Cancer Research and Clinical Oncology. 138, 7, p. 1187-1196 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Endothelial Cells
Biomarkers
Therapeutics
Disease-Free Survival
57 Citations (Scopus)
Salvage Therapy
Melphalan
Thalidomide
Amyloidosis
Dexamethasone
2011
4 Citations (Scopus)

A Metachronous splenic metastases from esophageal cancer: A case report

Botrugno, I., Jemos, V., Cobianchi, L., Fiandrino, G., Brugnatelli, S., Perfetti, V., Vercelli, A., Maestri, M. & Dionigi, P., Sep 16 2011, In : World Journal of Surgical Oncology. 9, 105.

Research output: Contribution to journalArticle

Esophageal Neoplasms
Adjuvant Chemotherapy
Neoplasm Metastasis
Esophagectomy
Splenectomy
1 Citation (Scopus)

Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: distinctive clinical features and role of light chain type in 225 patients.

Russo, P., Palladini, G., Foli, A., Zenone Bragotti, L., Milani, P., Nuvolone, M., Obici, L., Perfetti, V., Brugnatelli, S., Invernizzi, R. & Merlini, G., Jun 2011, In : Amyloid. 18 Suppl 1, p. 87-88 2 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: Distinctive clinical features and role of light chain type in 225 patients

Russo, P., Palladini, G., Foli, A., Zenone Bragotti, L., Milani, P., Nuvolone, M., Obici, L., Perfetti, V., Brugnatelli, S., Invernizzi, R. & Merlini, G., Jun 2011, In : Amyloid. 18, SUPPL. 1, p. 92-93 2 p.

Research output: Contribution to journalArticle

Amyloidosis
Light
Liver
Clone Cells
Immunoglobulin Light Chains
13 Citations (Scopus)

Single-dose palonosetron and dexamethasone in preventing nausea and vomiting induced by moderately emetogenic chemotherapy in breast and colorectal cancer patients

Brugnatelli, S., Gattoni, E., Grasso, D., Rossetti, F., Perrone, T. & Danova, M., May 2011, In : Tumori. 97, 3, p. 362-366 5 p.

Research output: Contribution to journalArticle

Nausea
Dexamethasone
Vomiting
Colorectal Neoplasms
Breast Neoplasms
2010
78 Citations (Scopus)

Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients

Ronzoni, M., Manzoni, M., Mariucci, S., Loupakis, F., Brugnatelli, S., Bencardino, K., Rovati, B., Tinelli, C., Falcone, A., Villa, E. & Danova, M., Dec 2010, In : Annals of Oncology. 21, 12, p. 2382-2389 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Biomarkers
Healthy Volunteers
Therapeutics
Endothelial Cells
2008
19 Citations (Scopus)
Carcinoembryonic Antigen
Colorectal Neoplasms
Survival
Survival Analysis
Proportional Hazards Models
9 Citations (Scopus)

UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen

Scalamogna, R., Brugnatelli, S., Tinelli, C., Sagrada, P., Gattoni, E., Tronconi, M. C., Riccardi, A., Luchena, G. & Corazza, G. R., Feb 2008, In : Oncology. 72, 5-6, p. 267-273 7 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Quality of Life
oxaliplatin
Hospitalization
2007
16 Citations (Scopus)
Intestinal Pseudo-Obstruction
Proteasome Inhibitors
Pharmaceutical Preparations
Plasmacytoma
Poisons
2006
4 Citations (Scopus)

Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: Results of a multicenter phase II study

Riccardi, A., Brugnatelli, S., Danova, M., Giordano, M., Pugliese, P., Luchena, G., Grasso, D., Trotti, G., Bertè, R., Pansini, G. & Tinelli, C., Jan 2006, In : Tumori. 92, 1, p. 6-12 7 p.

Research output: Contribution to journalArticle

docetaxel
gemcitabine
Epirubicin
Breast Neoplasms
Therapeutics
2005
70 Citations (Scopus)

Dendritic cells and vascular endothelial growth factor in colorectal cancer: Correlations with clinicobiological findings

Della Porta, M., Danova, M., Rigolin, G. M., Brugnatelli, S., Rovati, B., Tronconi, C., Fraulini, C., Rossi, A. R., Riccardi, A. & Castoldi, G., Jul 2005, In : Oncology. 68, 2-3, p. 276-284 9 p.

Research output: Contribution to journalArticle

Dendritic Cells
Vascular Endothelial Growth Factor A
Colorectal Neoplasms
Blocking Antibodies
HLA-DR Antigens
20 Citations (Scopus)

Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes

Invernizzi, R., Travaglino, E., De Amici, M., Brugnatelli, S., Ramajoli, I., Rovati, B., Benatti, C. & Ascari, E., Jun 2005, In : Leukemia Research. 29, 6, p. 641-647 7 p.

Research output: Contribution to journalArticle

Thalidomide
Myelodysplastic Syndromes
Bone Marrow Cells
Apoptosis
Matrix Metalloproteinase 2
1 Citation (Scopus)

Unusual CT findings in urachus carcinoma with an extensive and atypical pattern of metastasis. A case report

La Fianza, A., Scalamogna, R., Gorone, M. S. P., Rovereto, B., Brugnatelli, S. & Viglio, A., May 2005, In : Tumori. 91, 3, p. 273-275 3 p.

Research output: Contribution to journalArticle

Urachus
Neoplasm Metastasis
Carcinoma
Neoplasms
Tomography
2003
14 Citations (Scopus)

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: Results of the MM87 prospective randomised protocol

Riccardi, A., Mora, O., Tinelli, C., Porta, C., Danova, M., Brugnatelli, S., Grasso, D., Tolcà, B., Spanedda, R., De Paoli, A., Barbarano, L., Cavanna, L., Giordano, M., Delfini, C., Nicoletti, G., Bergonzi, C., Rinaldi, E., Piccinini, L. & Ascari, E., Jan 2003, In : European Journal of Cancer. 39, 1, p. 31-37 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Drug Therapy
Survival
Neoplasms
2002
4 Citations (Scopus)

Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transplantation [2]

Ferrari, S., Danova, M., Porta, C., Brugnatelli, S., Pugliese, P., Bertolini, A. & Riccardi, A., 2002, In : Annals of Hematology. 81, 6, p. 354-356 3 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)

Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: A phase 1 study

Brugnatelli, S., Danova, M., De Bella, M. T., Vaglica, M., Manuguerra, G., Riccardi, A. & Palmeri, S., 2002, In : Oncology. 62, 1, p. 33-38 6 p.

Research output: Contribution to journalArticle

docetaxel
gemcitabine
Breast Neoplasms
Asthenia
Stomatitis
2001
8 Citations (Scopus)

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)

Riccardi, A., Pugliese, P., Danova, M., Brugnatelli, S., Grasso, D., Giordano, M., Bernardo, G., Giardina, G., Fava, S., Montanari, G., Pedrotti, C., Trotti, G., Rinaldi, E., Poli, M. A. & Tinelli, C., 2001, In : British Journal of Cancer. 85, 2, p. 141-146 6 p.

Research output: Contribution to journalArticle

Epirubicin
Paclitaxel
Fluorouracil
Cyclophosphamide
Breast Neoplasms
10 Citations (Scopus)
docetaxel
Anthracyclines
Breast Neoplasms
Cytostatic Agents
Therapeutics
2000
5 Citations (Scopus)

Acute rhabdomyolysis after high-dose chemotherapy and circulating progenitor cell autografting for breast cancer

Pugliese, P., Danova, M., Brugnatelli, S., Piccolo, G., Riccardi, A. & Ascari, E., 2000, In : Haematologica. 85, 6, p. 672 1 p.

Research output: Contribution to journalArticle

Rhabdomyolysis
Autologous Transplantation
Cell Transplantation
Stem Cells
Breast Neoplasms
5 Citations (Scopus)
docetaxel
Taxoids
Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cells
Paclitaxel
24 Citations (Scopus)

Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer.

Riccardi, A., Tinelli, C., Brugnatelli, S., Pugliese, P., Giardina, V., Giordano, M., Danova, M., Richetti, A., Fava, S., Rinaldi, E., Fregoni, V., Trotti, G. & Poli, A., Apr 2000, In : International Journal of Oncology. 16, 4, p. 769-776 8 p.

Research output: Contribution to journalArticle

Epirubicin
Fluorouracil
Cyclophosphamide
Quality of Life
Breast Neoplasms
83 Citations (Scopus)

Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: A multicentre randomized study

Riccardi, A., Mora, O., Tinelli, C., Valentini, D., Brugnatelli, S., Spanedda, R., De Paoli, A., Barbarano, L., Di Stasi, M., Giordano, M., Delfini, C., Nicoletti, G., Bergonzi, C., Rinaldi, E., Piccinini, L. & Ascari, E., 2000, In : British Journal of Cancer. 82, 7, p. 1254-1260 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Multicenter Studies
Disease Progression
Drug Therapy
Melphalan
1999
8 Citations (Scopus)

Circulating progenitor cell release and functional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients.

Ferrari, S., Danova, M., Porta, C., Comolli, G., Brugnatelli, S., Pugliese, P., Riccardi, A. & Ascari, E., Oct 1999, In : International Journal of Oncology. 15, 4, p. 811-815 5 p.

Research output: Contribution to journalArticle

Topotecan
Small Cell Lung Carcinoma
Granulocyte Colony-Stimulating Factor
Erythropoietin
Stem Cells
1998
2 Citations (Scopus)

Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer

Riccardi, A., Brugnatelli, S., Giordano, M., Danova, M., Pugliese, P., Tinelli, C., Klersy, C., Richetti, A., Fava, S., Nastasi, G., Rinaldi, E., Fregoni, V., De Monte, A., Trotti, G., Bovio, A. & Ascari, E., 1998, In : Tumori. 84, 5, p. 540-546 7 p.

Research output: Contribution to journalArticle

Epirubicin
Granulocyte Colony-Stimulating Factor
Fluorouracil
Cyclophosphamide
Breast Neoplasms
4 Citations (Scopus)

Paclitaxel in anthracycline-treated breast cancer patients

Pugliese, P., Brugnatelli, S., Giordano, M., Danova, M., De Monte, A., Richetti, A., Fava, S., Rinaldi, E., Fregoni, V., Epifani, C. & Riccardi, A., 1998, In : Oncology Reports. 5, 4, p. 915-918 4 p.

Research output: Contribution to journalArticle

Anthracyclines
Paclitaxel
Breast Neoplasms
Epirubicin
Leukopenia
23 Citations (Scopus)

Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: Updated results of the MM87 prospective randomized protocol

Riccardi, A., Mora, O., Brugnatelli, S., Tinelli, C., Spanedda, R., De Paoli, A., Barbarano, L., Di Stasi, M., Bergonzi, C., Giordano, M., Delfini, C., Nicoletti, G., Rinaldi, E., Piccinini, L., Valentini, D. & Ascari, E., 1998, In : British Journal of Cancer. 77, 3, p. 485-491 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Drug Therapy
Survival
1996
58 Citations (Scopus)

A prognostic index for multiple myeloma

Grignani, G., Gobbi, P. G., Formisano, R., Pieresca, C., Ucci, G., Brugnatelli, S., Riccardi, A. & Ascari, E., 1996, In : British Journal of Cancer. 73, 9, p. 1101-1107 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Prednisone
Melphalan
Plasma Cells
Survival
3 Citations (Scopus)

Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma

Brugnatelli, S., Riccardi, A., Ucci, G., Mora, O., Barbarano, L., Piva, N., Piccinini, L., Bergonzi, C., De Paoli, A., Di Stasi, M., Rinaldi, E., Trotti, G., Petrini, M. & Ascari, E., 1996, In : British Journal of Cancer. 73, 6, p. 794-797 4 p.

Research output: Contribution to journalArticle

Epirubicin
Prednisone
Multiple Myeloma
Cyclophosphamide
Interferons
3 Citations (Scopus)

Oral idarubicin and prednisone for advanced, previously untreated, multiple myeloma: a pilot study. Cooperative Group of Study and Treatment of Multiple Myeloma.

Brugnatelli, S., Riccardi, A., Ucci, G., Petrini, M., Giordano, M., Barbarano, L., Bergonzi, C., De Paoli, A., Cavanna, L. & Ascari, E., Jul 1996, In : Annals of Oncology. 7, 5, p. 537-538 2 p.

Research output: Contribution to journalArticle

Oral idarubicin and prednisone for advanced, previously untreated, multiple myeloma: A pilot study [3]

Brugnatelli, S., Riccardi, A., Ucci, G., Petrini, M., Giordano, M., Barbarano, L., Bergonzi, C., De Paoli, A., Cavanna, L. & Ascari, E., 1996, In : Annals of Oncology. 7, 5, p. 538 1 p.

Research output: Contribution to journalArticle

1995
4 Citations (Scopus)

Advanced breast cancer: A randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil

Riccardi, A., Giordano, M., Brugnatelli, S., Ucci, G., Danova, M., Mora, O., Fava, S. & Ascari, E., 1995, In : Oncology Reports. 2, 4, p. 577-582 6 p.

Research output: Contribution to journalArticle

Epirubicin
Fluorouracil
Cyclophosphamide
Breast Neoplasms
Anthracyclines
7 Citations (Scopus)

Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancer

Riccardi, A., Giordano, M., Brugnatelli, S., Ucci, G., Danova, M., Mora, O., Fava, S. & Ascari, E., 1995, In : European Journal of Cancer. 31, 9, p. 1549-1551 3 p.

Research output: Contribution to journalArticle

1994
2 Citations (Scopus)

A short term infusion regimen of cisplatin, 5-fluorouracil and L-folinic acid in advanced head and neck carcinoma

Meli, M., Palmeri, S., Leonardi, V., Danova, M., Failla, G., Russo, A., Brugnatelli, S., Ferrara, P., Benazzo, M. & Rausa, L., 1994, In : Oncology Reports. 1, 6, p. 1133-1138 6 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma

Riccardi, A., Ucci, G., Brugnatelli, S., Mora, O., Merlini, G., Piva, N., De Paoli, A., Barbarano, L., Di Stasi, M., Alberio, F., Nicoletti, G., Morandi, S., Rinaldi, E., Piccinini, L. & Ascari, E., 1994, In : International Journal of Oncology. 5, 4, p. 833-839 7 p.

Research output: Contribution to journalArticle

Clodronic Acid
Diphosphonates
Multiple Myeloma
Bone Resorption
Survival
23 Citations (Scopus)

Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cytostatic policy

Riccardi, A., Ucci, G., Luoni, R., Brugnatelli, S., Mora, O., Spanedda, R., De Paoli, A., Barbarano, L., Di Stasi, M., Alberio, F., Delfini, C., Nicoletti, G., Morandi, S., Rinaldi, E., Piccinini, L., De Pasquale, A. & Ascari, E., Dec 1994, In : British Journal of Cancer. 70, 6, p. 1203-1210 8 p.

Research output: Contribution to journalArticle

Cytostatic Agents
Multiple Myeloma
Prospective Studies
Combination Drug Therapy
Peptichemio
1993
5 Citations (Scopus)
Granulocyte-Macrophage Colony-Stimulating Factor
Hodgkin Disease
Drug Therapy
Lomustine
Procarbazine